Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence

Area of Science:

• Oncology
• Biotechnology
• Immunohistochemistry

Background:

• Multiplex immunofluorescence (mIF) with tyramide signal amplification is an emerging technique for cancer research.
• mIF allows for the simultaneous detection of multiple protein markers on a single tissue slide.
• High-quality staining and reproducible results are critical for accurate cancer studies using mIF.

Purpose of the Study:

• To describe the multiplex immunofluorescence (mIF) panel workflow.
• To discuss challenges and solutions for achieving high reproducibility in mIF studies.
• To provide guidance for optimizing mIF techniques in cancer research.

Main Methods:

• Review of existing literature and best practices for mIF panel workflow.
• Discussion of critical steps including antibody selection, optimization, and validation.
• Analysis of pre-analytic, analytic, and post-analytic factors influencing mIF reproducibility.

Main Results:

• mIF offers flexibility but faces challenges in reproducibility across different settings.
• Key factors for reproducibility include antibody validation, panel design, and staining optimization.
• Tissue handling processes (fixation, storage, cutting) can impact mIF results.

Conclusions:

• Standardizing the mIF workflow is essential for reliable and reproducible cancer research.
• Addressing pre-analytic and analytic variables is crucial for minimizing technical issues.
• Careful attention to antibody selection, validation, and panel design ensures data integrity.